Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
An Open-Label, Non-Randomized, Multicenter, Two-Stage, Phase 2 Study of S-1 in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: Quintiles, Inc.
A PHASE2 clinical study on Locally Advanced or Metastatic Pancreatic Cancer, this trial is completed. The trial is conducted by Quintiles, Inc. and has accumulated 10 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2022 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE2
▶ Show 5 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Apr 2020 — Sep 2020 [monthly]
Completed PHASE2
-
Jun 2018 — Apr 2020 [monthly]
Completed PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Quintiles, Inc.
- Taiho Oncology, Inc.
- United BioSource, LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.